The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs has announced the FY2012 SBIR Phase II Bridge Award, designed to support the next stage of development for previously funded NIH-wide SBIR Phase II projects in the areas of cancer therapeutics, imaging technologies, interventional devices, diagnostics and prognostics. The NCI intends to commit up to $10 million in fiscal year 2012 to fund up to ten new awards.
The Phase II Bridge Awards are designed to “Bridge” the funding gap, known as the “Valley of Death,” that currently exists between the end of the SBIR Phase II award and the next round of financing needed to advance a promising cancer therapy or imaging technology toward commercialization. The NCI
created the Bridge Award program to incentivize partnerships between NIH’s SBIR Phase II awardees and third-party investors and/or strategic partners.
For more information on this funding announcement, please visit: http://grants1.nih.gov/grants/guide/rfa-files/RFA-CA-12-001.html.
Applications are due: December 28, 2011 and March 27, 2012
To learn more about the SBIR Phase II Bridge Award, please visit: http://sbir.cancer.gov/funding/phase2bridgeaward.asp